Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KRX/302440 stock hub

KRX/302440 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/302440is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.3T

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/302440

In the news

Latest news · KRX/302440

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-2.8

P25 -17.1P50 0.7P75 8.5

ROIC-8

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/302440 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

KRW

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	917
Enterprise value	KRW 3.1T
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7302440003
Last refreshed	2026-05-10
Market cap	KRW 3.3T
Price	KRW 42,300
Price currency	KRW
Rev Per Employee	710,325,346.26x
Sector	Healthcare
Sic	2836
Symbol	krx/302440
Website	https://www.skbioscience.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.73%
EV Earnings	-54.52x
EV/FCF	-38.85x
EV/Sales	4.81x
FCF yield	-2.43%
P/B ratio	1.63x
P/S ratio	5.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-18.96%
EBITDA Margin	-4.99%
Gross margin	11.54%
Gross Profit	KRW 75.2B
Gross Profit Growth	149.93%
Gross Profit Growth Q	-4.33%
Gross Profit Growth3 Y	-32.02%
Net Income	KRW -57.4B
Net Income Growth Years	0%
Pretax Margin	-13.18%
Profit Margin	-8.82%
Profit Per Employee	KRW -62.6M
ROA	-2.66
ROCE	-4.7
ROE	-2.77
ROIC	-8.02
Roic5y	119.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.03%
Cagr3y	-20.15%
Cagr5y	-23.41%
EPS Growth Years	0
Revenue Growth	143.46x
Revenue Growth Q	17.43x
Revenue Growth Quarters	5x
Revenue Growth Years	1x
Revenue Growth3 Y	12.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.22
Assets	KRW 3T
Cash	KRW 906.3B
Current Assets	KRW 1.2T
Current Liabilities	KRW 326.2B
Debt	KRW 470B
Debt Equity	KRW 0.23
Debt FCF	KRW -5.83
Equity	KRW 2T
Interest Coverage	-13.14
Liabilities	KRW 918.3B
Long Term Assets	KRW 1.7T
Long Term Liabilities	KRW 592.1B
Net Cash	KRW 436.3B
Net Cash By Market Cap	KRW 13.15
Net Cash Growth	-42.99%
Net Debt Equity	KRW -0.21
Tangible Book Value	KRW 1.7T
Tangible Book Value Per Share	KRW 21,186
WACC	8.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.82
Inventory Turnover	2.88
Net Working Capital	KRW 17.3B
Quick ratio	3.19
Working Capital	KRW 919.9B
Working Capital Turnover	KRW 0.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.02%
200-day SMA	48,110.5
3Y total return	-49.1%
50-day SMA	43,388
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.64%
All Time High	362,000
All Time High Change	-88.31%
All Time High Date	2021-08-17
All Time Low	35,800
All Time Low Change	18.16%
All Time Low Date	2025-04-09
ATR	1,348.6
Beta	0.93
Beta1y	0.53
Beta2y	0.69
Ch YTD	-12.24
High	42,750
High52	61,300
High52 Date	2025-11-04
High52ch	-31%
Low	41,700
Low52	39,250
Low52 Date	2025-05-12
Low52ch	9.3%
Ma50ch	-2.51%
Price vs 200-day SMA	-12.08%
RSI	44.58
RSI Monthly	40.85
RSI Weekly	40.58
Sharpe ratio	0.24x
Sortino ratio	0.56
Total Return	-1.51%
Tr YTD	-12.24
Tr1m	4.96%
Tr1w	-2.31%
Tr3m	-13.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -123.5B
Operating margin	-18.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,948,654%
Net Borrowing	40,805,525,970
Shares Insiders	0.17%
Shares Institutions	2.44%
Shares Out	78,456,553
Shares Qo Q	0.22%
Shares Yo Y	1.51%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -80.6B
Average Volume	119,082.35x
Bv Per Share	22,806.2
CAPEX	KRW -183.1B
Ch1m	4.96
Ch1w	-2.31
Ch1y	9.02
Ch3m	-13.5
Ch3y	-49.1
Ch5y	-73.64
Ch6m	-21.52
Change	0.71%
Change From Open	-0.7
Close	42,000
Days Gap	1.43
Depreciation Amortization	91,015,613,000
Dollar Volume	4,380,461,100
Earnings Date	2026-08-12
EBIT	KRW -123.5B
EBITDA	KRW -32.5B
EPS	KRW -733
F Score	4
FCF	KRW -80.6B
FCF EV Yield	-2.57x
FCF Per Share	KRW -1,027
Financing CF	41,600,226,790
Fiscal Year End	December
Founded	2,018
Goodwill	55,252,859,000
Income Tax	KRW -29.7B
Investing CF	-361,760,173,270
Is Primary Listing	1
Last Earnings Date	2026-02-03
Last Report Date	2025-12-31
Ma150	48,237
Ma150ch	-12.31%
Ma20	43,497.5
Ma20ch	-2.75%
Net CF	-207,148,615,000
Next Earnings Date	2026-08-12
Open	42,600
P OCF Ratio	32.38
Position In Range	57.14
Ppne	1,130,387,063,560
Price Date	2026-05-08
Ptbv Ratio	2
Relative Volume	0.86x
Revenue	651,368,342,520x
Tax By Revenue	-4.56x
Tr6m	-21.52%
Volume	103,557
Z Score	3.08

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/302440 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/302440 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/302440?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.4%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.5%

Negative means the company is buying back shares.

Technical

KRX/302440 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.6

Neutral momentum band

Price vs 200-day MA

-12.1%

50/200-day relationship not available

Beta (5Y)

0.93

Moves roughly with the market

Sharpe ratio

0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/302440

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/302440 stock rating?

krx/302440 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/302440 analysis?

The full report lives at /stocks/krx/302440/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/302440?

The latest report frames krx/302440 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/302440 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.